|Mr. Mordechai Bignitz CPA||CEO, Pres & Director||118k||N/A||1951|
|Mr. Alon Sinai||Chief Operating Officer||94k||N/A||1967|
|Dr. Yehuda Baruch||Chief Medical & Regulatory Affairs Officer||112k||N/A||1957|
|Ms. Sigal Russo-Gueta||Chief Financial Officer||N/A||N/A||1978|
|Dr. Oron Yacoby-Zeevi||Chief Scientific Officer||N/A||N/A||1961|
OWC Pharmaceutical Research Corp., through its subsidiary, One World Cannabis Ltd., engages in the research and development of cannabis-based medical products. It develops cannabis-based medical products for the treatment of various conditions, including multiple myeloma, psoriasis, post-traumatic stress disorder, chronic pain, and fibromyalgia. The company is also involved in developing cannabis soluble tablet delivery system. In addition, it provides consulting services to companies and governmental agencies related to international medical cannabis protocols and regulations. The company was formerly known as Dynamic Applications Corp. and changed its name to OWC Pharmaceutical Research Corp. in December 2014. OWC Pharmaceutical Research Corp. was founded in 2008 and is based in Ramat Gan, Israel.
OWC Pharmaceutical Research Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.